The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 30, 2021

Filed:

Feb. 11, 2021
Applicant:

Nanopharmaceuticals, Llc, Rensselaer, NY (US);

Inventors:

Shaker A. Mousa, Wynantskill, NY (US);

Bruce A. Hay, Niskayuna, NY (US);

Assignee:

NANOPHARMACEUTICALS LLC, Rensselaer, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 249/04 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
C07D 249/04 (2013.01); A61P 35/00 (2018.01);
Abstract

Chemical compounds/compositions, methods of synthesis, and methods of use. The compounds/compositions are directed toward thyrointegrin antagonists conjugated to a polymer. The compounds/compositions further comprise an additional substituent also conjugated to the polymer. The compounds/compositions demonstrate increased uptake across the blood brain barrier along with increased retention therein and retention within tumor. The compounds/compositions may also include improved synthesis scalability, improved purity, improved aqueous solubility, and a solid product or intermediate. The compounds/compositions may demonstrate improved antiangiogenic effect and improved efficacy against conditions, particularly cancers, requiring blood brain barrier permeability, for example, glioblastoma (GBM).


Find Patent Forward Citations

Loading…